Pazopanib and Weekly Paclitaxel in Stage IIIB/IV Non-small Cell Lung Cancer.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2016
At a glance
- Drugs Paclitaxel; Pazopanib
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 Oct 2016 Status changed from recruiting to withdrawn prior to enrolment.
- 13 Sep 2011 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 09 Mar 2011 Planned initiation date changed from Sep 2010 to Jun 2011 as reported by ClinicalTrials.gov.